Nidan Laborator. — 360° view

Nidan Laborator, a company in the Healthcare Service Provider industry, reported revenue of ₹12 crore and net profit of ₹1.09 crore for the September 2026 quarter.

Nidan Laborator. (NSE: NIDAN-SM) closed at ₹13.00 on 20 Nov 2026, down 35.5% over the past year. Its market capitalisation is ₹18 crore and it trades at 14.9 times earnings.

Share price
₹13.00 (20 Nov 2026)
Market cap
₹18 Cr (20 Nov 2026)
P/E
14.93 (20 Nov 2026)
Revenue
₹12 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
5.99% (FY26)
ROE
2.58% (FY26)
Book value
₹50.9 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹24.90 / ₹11.50 (20 Nov 2026)
1-year return
-35.5% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
NSE: NIDAN-SM

Incorporated in 2000, Nidan Laboratories & Healthcare Ltd is in the business of providing various Healthcare and Diagnostics Services

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.